NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 129 filers reported holding NOVOCURE LTD in Q4 2017. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $569,233 | -75.8% | 4,900 | -64.0% | 0.00% | -77.8% |
| Q4 2020 | $2,353,344 | +13.4% | 13,600 | -61.1% | 0.02% | -25.0% |
| Q2 2020 | $2,076,000 | +606.1% | 35,000 | +472.6% | 0.02% | +1100.0% |
| Q1 2019 | $294,000 | -95.4% | 6,113 | -98.1% | 0.00% | -95.3% |
| Q3 2017 | $6,451,000 | +7579.8% | 325,000 | +3026.8% | 0.04% | +4200.0% |
| Q1 2017 | $84,000 | – | 10,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |